Horizon sponsored the First Annual Labroots CRISPR Virtual Event.
With continued adoption and integration in research labs, CRISPR gene editing has gained importance both as a research tool in drug discovery, screening, and therapeutic development. This inaugural event brought together thought leaders from academia, trained researcher from clinical laboratories, and industry experts from pharmaceutical to biotech.
This exciting new field is faced with new challenges and limitations. Experts shared case studies and experiences regarding best practices to guide RNA design, effects associated with CRISPR/Cas and address appropriate alternatives that are currently being developed.
The 2018 event covered a range of topics, such as:
- In Vivo Genome Editing with CRISPR
- Engineering T Cell Circuitry
- Harnessing CRISPR-Cas9 to Enhance Genome Editing
- Measurements and Standards
- CRISPR-Based Gene Editing for Drug Discovery and Targeted Therapies
- Next-gen editing tools
This complimentary conference offered a fantastic opportunity for a global community of like-minded colleagues to interact from the comfort of home. Topics of discussion included the distinctions and abilities of CRISPR-based editing, next-gen editing tools, precision in gene editing and using CRISPR for drug discovery.